SERPINA3 and COVID-19: A cohort of 71 patients (20 controls, 19 with non-critical COVID-19, and 33 with critical COVID-19) was studied in India [33], and the authors found higher serum SerpinA3 in patients with critical COVID-19, as a surrogate of disease severity.